Trial
NCT05999799
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Dermatitis, Atopic
Intervention
GSK1070806
Why stopped
Sponsor decision to early terminate the study based on the pre-defined futility criterion for efficacy. No safety concerns were identified.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-03